ACADIA Pharmaceuticals In...

NASDAQ: ACAD · Real-Time Price · USD
25.18
0.65 (2.65%)
At close: Aug 15, 2025, 1:20 PM

ACADIA Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
226.45M -61.29M -215.97M -167.87M
Depreciation & Amortization
15.88M 5.55M 2.03M 3.34M
Stock-Based Compensation
67.05M 66.42M 68.2M 63.62M
Other Working Capital
57.4M 81.41M 27.54M -2.88M
Other Non-Cash Items
-155.82M -12.12M -6.28M 75K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
4.16M 18.13M 37.99M -24.82M
Operating Cash Flow
157.72M 16.7M -114.03M -125.66M
Capital Expenditures
-523K -40.05M n/a -1.12M
Cash Acquisitions
n/a -32.05M n/a 69.98M
Purchase of Investments
-505.1M -369.99M -363.17M -492.8M
Sales Maturities Of Investments
328.56M 442.03M 436.42M 422.82M
Other Investing Acitivies
146.51M 32.05M 73.24M -69.98M
Investing Cash Flow
-30.54M 32M 73.24M -71.1M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
6.84M 25.13M 8.2M 18.16M
Net Cash Flow
133.93M 73.81M -32.59M -178.59M
Free Cash Flow
157.2M -23.35M -114.03M -126.78M